Ciitizen
Edit

Ciitizen

http://www.ciitizen.com/
Last activity: 01.12.2022
Probably Closed
Categories: Artificial IntelligenceB2CDataHealthTechInformationLearnMedTechPlatformStoreTechnology
Ciitizen is a patient-centric consumer health technology platform that enables patients to collect, store and share their medical records in a single location. Ciitizen developed proprietary machine learning and AI technologies to abstract critical information from unstructured health records to advance the understanding of diseases, match patients with potentially life-saving clinical trials, and enable better care decisions. Ciitizen also provides valuable big data analytics and data quality technologies to the network of Health Information Exchanges (HIEs) to produce research-ready, regulatory-grade data within minutes, instead of hours or days, and ensure HIEs can comply with the Information Blocking regulations.

Ciitizen was acquired by Invitae in September, 2021.
Mentions
27
Location: United States, California, Palo Alto
Total raised: $20M

Investors 7

Funding Rounds 2

DateSeriesAmountInvestors
16.01.2019Series A$17M-
26.07.2018-$3M-

Mentions in press and media 27

DateTitleDescription
01.12.2022Contributed: How digital health can improve cancer care deliveryPhoto: FG Trade/Getty Images
07.09.2021 Wavemaker Three-Sixty Health Gets Exit At Ciitizen Los Angeles-based healthcare venture capital investor Wavemaker Three-Sixty Health has scored an exit in its portfolio, through the acquisition of Ciitizen by Invitae. According to Wavemaker Health, Ciitizen was its third investment in its ...
07.09.2021Venture investors look for the next hot thing outside India and ChinaThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Does your company need a Chief A.I. Ethics Officer, an A.I. Ethicist, an A.I. Ethics...
07.09.2021Venture investors look for the next hot thing outside India and ChinaThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content How to ensure your marketers stay dynamic and agile From Optimizely In the hopes rid...
07.09.2021Genetic testing company Invitae snaps up digital health record company Ciitizen for $325MPhoto: FatCamera/Getty Images
18.08.2021Ciitizen to Launch Cures Gateway Enabling Health Information Exchanges to Effortlessly Comply With 21st Century Cures Act Information Blocking RuleRochester RHIO is the first HIE in the Ciitizen network to benefit from simplified process for sharing clinical data with patients and their apps Ciitizen, a consumer healthcare technology company helping patients get full control of their ...
16.08.2021Ciitizen Launches Solution to Help HIEs Comply with Info Blocking RegulationWhat You Should Know: – Ciitizen, a Palo Alto, CA-based consumer healthcare technology company helping patients get full control of their medical records to access more personalized treatment options, today announced the launch of Cures Gat...
09.07.2021Invitae Acquires Ciitizen for $325M to Strengthen its Patient-Consented Health Data PlatformWhat You Should Know: – Medical genetics company Invitae today announced its $325M acquisition of Ciitizen, a patient-centric consumer health tech company that offers a global platform to help patients collect, organize, store and share the...
14.05.2021‘It’s not over yet’: Uncertain protection from Covid vaccines leaves cancer patients in limboAfter 14 long months of near-isolation, Michele Nadeem-Baker was ready for her Covid-19 vaccination. Diagnosed with chronic lymphocytic leukemia in 2012, she knew her cancer made her more vulnerable to severe illness should she become infec...
04.05.2021Ciitizen : Acquires Key Technology and Creates New Healthcare Data Infrastructure for Improving Patient and Doctor Information AccessCiitizen, a healthcare technology company helping patients get full control of their medical records to access more personal treatment options including participation in research and clinical trials, today announced the acquisition of Stell...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In